Skip to search formSkip to main contentSkip to account menu

TMEM30A gene

Known as: CDC50, S. CEREVISIAE, HOMOLOG OF, A, TRANSMEMBRANE PROTEIN 30A, FLJ10856 
National Institutes of Health

Related topics

Related topics

1 relation
TMEM40 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract 3480:TMEM30Aloss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype worldwide, accounting for 40% of all non-Hodgkin… 
2018
2018
Tmem30a plays critical roles in retina vascular development
2018
2018
Tmem30a deficiency leads to retinal rod bipolar cell degeneration
2018
2018
Abstract 5454: New insights into the mode of action of cytotoxic alkyl-phospholipids
Background: Synthetic alkyl-phospholipid analogs (APLs), such as Edelfosine and Perifosine, are a class of anti-tumor agents that… 
2017
2017
A biosystems approach to identify the molecular signaling mechanisms of TMEM30A during tumor migration
Understanding the molecular mechanisms underlying cell migration, which plays an important role in tumor growth and progression… 
2017
2017
Phospholipid Flippase Activity and Cellular Function of Class 5 P4-ATPases
................................................................................ 12 INTRODUCTION… 
2015
2015
Characterization of P4 ATPase Phospholipid Translocases (Flippases) in Human and Rat Pancreatic Beta Cells
Background: Flippases translocate phosphatidylserine (PS) across lipid bilayers in secretory granules (SG) and plasma membranes… 
Review
2013
Review
2013
Great challenges in molecular medicine: toward personalized medicine
  • M. Katoh
  • Front. Cell Dev. Biol.
  • 2013
  • Corpus ID: 2400595
GENE HUNTING, SIGNALING NETWORK, AND MOLECULAR MEDICINE In the 20th century, most researchers investigated WNT signaling in cell… 
2011
2011
Abstract 5456: Functional genomics reveals diverse cellular processes that modulate tumor cell response to oxaliplatin
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Oxaliplatin is widely used to treat colorectal cancer… 
2010
2010
CDC50A plays a key role in the uptake of the anticancer drug perifosine in human carcinoma cells.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)